Dr. Gillett And James O'Hara NP, discuss the Semaglutide and Tirzepatide. 00:00 Intro 01:46 Why might we suggest this? 05:20 Titration schedule 06:28 Why they designed this study this way 12:04 Ai 15:35 Who should use GLP1s 17:33 Costs of GLP1s 23:35 Closing points Studies/References: ► https://www.epicresearch.org/articles/tirzepatide-and-injectable-semaglutide-correlated-with-greatest-weight-loss-among-glp-1-medications ► https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8987449/ For High-quality labs: ► https://gilletthealth.com/order-lab-panels/ For information on the Gillett Health clinic, lab panels, and health coaching: ► https://GillettHealth.com Follow Gillett Health for more content from James and Kyle ► https://instagram.com/gilletthealth ► https://www.tiktok.com/@gilletthealth ► https://twitter.com/gilletthealth ► https://www.facebook.com/gilletthealth Follow Kyle Gillett, MD ► https://instagram.com/kylegillettmd Follow James O’Hara, NP ► https://Instagram.com/jamesoharanp For 10% off Gorilla Mind products including SIGMA: Use code “GH10” ► https://gorillamind.com/ For discounts on high-quality supplements ►https://www.thorne.com/u/GillettHealth #weightloss #podcast #ai Advertising Inquiries: https://redcircle.com/brands Privacy & Opt-Out: https://redcircle.com/privacy